An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Use of Dietary Supplements in the United States

A Case Study Providing a Potential Link Between Long-COVID and Vestibular Symptoms 

Utility of Rotary Chair Testing 

Recent Posts

Use of Dietary Supplements in the United States

Audiologists, as part of their clinical practice, may review and/or solicit information regarding their patient’s medications. While a given patient may take prescription medications, some…

Read More

A Case Study Providing a Potential Link Between Long-COVID and Vestibular Symptoms 

The case report, Relative Brain Perfusion Differences in a Patient with Persistent Neurocognitive and Vestibular Symptoms Associated with Post-COVID-19 Condition: A Case Report (Pham, 2026), describes…

Read More

Utility of Rotary Chair Testing 

In a recent article, Advances in the Clinical Application of Rotational Chair Testing for the Diagnosis and Management of Vestibular Disorders (Ganggang et al., 2026), the…

Read More